J H Moon1, J S Huh, C W Won, H J Kim. 1. Chang Won Won and Hyeon Ju Kim, Department of Family Medicine, Jeju National University School of Medicine, Jeju, Republic of Korea, fmhjukim@hanmail.net; Tel.: +82-64-754-8153 (H.J.K.), chuwon62@naver.com; Tel.:+82-2-958-8700 (C.W.W.).
Abstract
OBJECTIVES: Cognitive frailty-the coexistence of physical frailty and cognitive impairment-is a phenotype of frailty in the elderly. The coexistence of physical frailty and cognitive impairment, known as cognitive frailty, is one of the phenotypes of frailty in the elderly. Cognitive frailty predicts adverse health outcome more accurately than does physical frailty. In this study, we aim to determine whether the polypharmacy common among the elderly is linked with cognitive frailty. DESIGN, SETTING, AND PARTICIPANTS: The elderly, aged between 70 and 84 years, who participated in the cross-sectional Korean Frailty and Aging Cohort Study were included in the present study. MEASUREMENTS: Polypharmacy and hyperpolypharmacy were defined as the use of at least five and ten medications, respectively. Physical frailty was assessed by the Korean version of the FRAIL scale, and cognitive status was measured by the Trail Making Test part A, word list recall test, the Korean version of the Frontal Assessment Battery, and the Digit Span Backward test. RESULTS: Among the 2,392 participants, 26.8% and 4.1% took more than five and ten prescribed medications, respectively. Polypharmacy and hyperpolypharmacy participants tend to have more cognitive impairment and physical frailty. Participants with cognitive frailty had the highest polypharmacy rate regardless of medication type. After controlling for the potential confounders including severity of comorbidities, frailty was found to be significantly related to polypharmacy, as defined by prescribed as well as total medications, including non-prescribed medications. However, cognitive impairment only showed a linkage to polypharmacy of prescribed medications, which-according to the results of multivariable analysis- could increase cognitive frailty, with an odds ratio of 2.70. CONCLUSION: Although the elderly tend to depend on various medications, they should seriously consider the risk of polypharmacy for better health outcomes.
OBJECTIVES: Cognitive frailty-the coexistence of physical frailty and cognitive impairment-is a phenotype of frailty in the elderly. The coexistence of physical frailty and cognitive impairment, known as cognitive frailty, is one of the phenotypes of frailty in the elderly. Cognitive frailty predicts adverse health outcome more accurately than does physical frailty. In this study, we aim to determine whether the polypharmacy common among the elderly is linked with cognitive frailty. DESIGN, SETTING, AND PARTICIPANTS: The elderly, aged between 70 and 84 years, who participated in the cross-sectional Korean Frailty and Aging Cohort Study were included in the present study. MEASUREMENTS: Polypharmacy and hyperpolypharmacy were defined as the use of at least five and ten medications, respectively. Physical frailty was assessed by the Korean version of the FRAIL scale, and cognitive status was measured by the Trail Making Test part A, word list recall test, the Korean version of the Frontal Assessment Battery, and the Digit Span Backward test. RESULTS: Among the 2,392 participants, 26.8% and 4.1% took more than five and ten prescribed medications, respectively. Polypharmacy and hyperpolypharmacy participants tend to have more cognitive impairment and physical frailty. Participants with cognitive frailty had the highest polypharmacy rate regardless of medication type. After controlling for the potential confounders including severity of comorbidities, frailty was found to be significantly related to polypharmacy, as defined by prescribed as well as total medications, including non-prescribed medications. However, cognitive impairment only showed a linkage to polypharmacy of prescribed medications, which-according to the results of multivariable analysis- could increase cognitive frailty, with an odds ratio of 2.70. CONCLUSION: Although the elderly tend to depend on various medications, they should seriously consider the risk of polypharmacy for better health outcomes.
Authors: Shelly L Gray; Melissa L Anderson; Rebecca A Hubbard; Andrea LaCroix; Paul K Crane; Wayne McCormick; James D Bowen; Susan M McCurry; Eric B Larson Journal: J Gerontol A Biol Sci Med Sci Date: 2013-02-18 Impact factor: 6.053
Authors: D Gnjidic; S N Hilmer; F M Blyth; V Naganathan; R G Cumming; D J Handelsman; A J McLachlan; D R Abernethy; E Banks; D G Le Couteur Journal: Clin Pharmacol Ther Date: 2012-02-01 Impact factor: 6.875
Authors: E Kelaiditi; M Cesari; M Canevelli; G Abellan van Kan; P-J Ousset; S Gillette-Guyonnet; P Ritz; F Duveau; M E Soto; V Provencher; F Nourhashemi; A Salvà; P Robert; S Andrieu; Y Rolland; J Touchon; J L Fitten; B Vellas Journal: J Nutr Health Aging Date: 2013-09 Impact factor: 4.075
Authors: Jung H Lee; Kang U Lee; Dong Y Lee; Ki W Kim; Jin H Jhoo; Ju H Kim; Kun H Lee; Sung Y Kim; Sul H Han; Jong I Woo Journal: J Gerontol B Psychol Sci Soc Sci Date: 2002-01 Impact factor: 4.077
Authors: Elsa Dent; Christopher Lien; Wee Shiong Lim; Wei Chin Wong; Chek Hooi Wong; Tze Pin Ng; Jean Woo; Birong Dong; Shelley de la Vega; Philip Jun Hua Poi; Shahrul Bahyah Binti Kamaruzzaman; Chang Won; Liang-Kung Chen; Kenneth Rockwood; Hidenori Arai; Leocadio Rodriguez-Mañas; Li Cao; Matteo Cesari; Piu Chan; Edward Leung; Francesco Landi; Linda P Fried; John E Morley; Bruno Vellas; Leon Flicker Journal: J Am Med Dir Assoc Date: 2017-07-01 Impact factor: 4.669
Authors: Reinhard Alzner; Ulrike Bauer; Stefan Pitzer; Maria Magdalena Schreier; Jürgen Osterbrink; Bernhard Iglseder Journal: Wien Med Wochenschr Date: 2016-02-05
Authors: Ahmed Abdelmajed Alkhodary; Syed Mohamed Aljunid; Aniza Ismail; Amrizal Muhammad Nur; Suzana Shahar Journal: Int J Environ Res Public Health Date: 2022-03-13 Impact factor: 3.390